Presented expert testimony before the competition authority analyzing the market for regulated health products in Spain. Dr. Marín’s testimony evaluated companies’ behavior under different regulatory regimes; compared prices and costs for alternative distribution channels; and discussed whether market structure and available price data were consistent with the alleged cartel activities.

Experts Involved